A Study of Suvorexant for Insomnia in People with Opioid Use Disorder
Phase 3
300
about 1.7 years
18–70
10 sites in CT, GA, MD +6
About this study
This trial is testing if suvorexant, a medication, helps people with opioid use disorder (OUD) sleep better. Researchers are also looking at how safe and well-tolerated suvorexant is compared to a placebo.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Placebo
- 2.Take Suvorexant
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
suvorexant
oral (Oral Tablet)
Primary: Change from Baseline in Total Sleep Time at Week 8, Number of Participants Who Discontinue Study Treatment Due to an AE, Number of Participants Who Experience One or More Adverse Events (AEs), Number of Participants Who Experience One or More Serious Adverse Events (SAEs)
Secondary: Change from Baseline in Wakefulness after Persistent Sleep Onset at Week 8